{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T15:23:30Z","timestamp":1769181810433,"version":"3.49.0"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1097\/bor.0b013e32834dc392","type":"journal-article","created":{"date-parts":[[2011,11,16]],"date-time":"2011-11-16T06:39:44Z","timestamp":1321425584000},"page":"31-37","source":"Crossref","is-referenced-by-count":42,"title":["Biologic treatment of large-vessel vasculitides"],"prefix":"10.1097","volume":"24","author":[{"given":"Valentin S.","family":"Sch\u00e4fer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jochen","family":"Zwerina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-6-20210128","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1161\/CIRCULATIONAHA.107.760686","article-title":"Aortitis.","volume":"117","author":"Gornik","year":"2008","journal-title":"Circulation"},{"key":"R3-6-20210128","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1136\/ard.2008.088351","article-title":"EULAR recommendations for the management of large vessel vasculitis.","volume":"68","author":"Mukhtyar","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"R4-6-20210128","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/art.20928","article-title":"Stable incidence of primary systemic vasculitides over five years: results from the German vasculitis register.","volume":"53","author":"Reinhold-Keller","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R5-6-20210128","first-page":"1103","article-title":"Negative temporal artery biopsies: eventual diagnoses and features of patients with biopsy-negative giant cell arteritis compared to patients without arteritis.","volume":"26","author":"Breuer","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"R6-6-20210128","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/rheumatology\/ken465","article-title":"Risk factors for severe cranial ischaemic events in an Italian population-based cohort of patients with giant cell arteritis.","volume":"48","author":"Salvarani","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"R7-6-20210128","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/rheumatology\/kem322","article-title":"Ultrasound of proximal upper extremity arteries to increase the diagnostic yield in large-vessel giant cell arteritis.","volume":"47","author":"Schmidt","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"R8-6-20210128","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/art.21699","article-title":"Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients.","volume":"55","author":"Blockmans","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R9-6-20210128","doi-asserted-by":"crossref","first-page":"3532","DOI":"10.1002\/art.11480","article-title":"Mortality of large-artery complication (aortic aneurysm, aortic dissection, andor large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years.","volume":"48","author":"Nuenninghoff","year":"2003","journal-title":"Arthritis Rheum"},{"key":"R10-6-20210128","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/art.11388","article-title":"Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes.","volume":"49","author":"Proven","year":"2003","journal-title":"Arthritis Rheum"},{"key":"R11-6-20210128","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/00041327-200503000-00004","article-title":"Predictors of recurrent ischemic optic neuropathy in giant cell arteritis.","volume":"25","author":"Chan","year":"2005","journal-title":"J Neuroophthalmol"},{"key":"R12-6-20210128","doi-asserted-by":"crossref","first-page":"106","DOI":"10.7326\/0003-4819-134-2-200101160-00010","article-title":"Combined treatment of giant-cell arteritis with methotrexate and prednisone: a randomized, double-blind, placebo-controlled trial.","volume":"134","author":"Jover","year":"2001","journal-title":"Ann Intern Med"},{"key":"R13-6-20210128","first-page":"495","article-title":"A prospective, double-blind, randomized, placebo controlled trial of methotrexate in the treatment of giant cell arteritis (GCA).","volume":"19","author":"Spiera","year":"2001","journal-title":"Clin Exp Rheumatol"},{"key":"R14-6-20210128","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/art.10262","article-title":"A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis.","volume":"46","author":"Hoffman","year":"2002","journal-title":"Arthritis Rheum"},{"key":"R15-6-20210128","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1002\/art.22754","article-title":"Adjunctive methotrexate for treatment of giant cell arteritis: an individual patient data meta-analysis.","volume":"56","author":"Mahr","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R16-6-20210128","first-page":"S43","article-title":"Cyclophosphamide for large vessel vasculitis: assessment of response by PETCT.","volume":"29","author":"Henes","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"R17-6-20210128","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1136\/ard.45.2.136","article-title":"Azathioprine in giant cell arteritispolymyalgia rheumatica: a double-blind study.","volume":"45","author":"De Silva","year":"1986","journal-title":"Ann Rheum Dis"},{"key":"R18-6-20210128","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/rheumatology\/37.4.464","article-title":"No additive effect of cyclosporin A compared with glucocorticoid treatment alone in giant cell arteritis: results of an open, controlled, randomized study.","volume":"37","author":"Schaufelberger","year":"1998","journal-title":"Br J Rheumatol"},{"key":"R19-6-20210128","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s002960050019","article-title":"Immuno-localisation of tumour necrosis factor and its receptors in temporal arteritis.","volume":"17","author":"Field","year":"1997","journal-title":"Rheumatol Int"},{"key":"R20-6-20210128","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1002\/1529-0131(200112)44:12<2933::AID-ART482>3.0.CO;2-Y","article-title":"Treatment of longstanding active giant cell arteritis with infliximab: report of four cases.","volume":"44","author":"Cantini","year":"2001","journal-title":"Arthritis Rheum"},{"key":"R21-6-20210128","doi-asserted-by":"crossref","first-page":"621","DOI":"10.7326\/0003-4819-146-9-200705010-00004","article-title":"Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial.","volume":"146","author":"Hoffman","year":"2007","journal-title":"Ann Intern Med"},{"key":"R22-6-20210128","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1136\/ard.2007.082115","article-title":"A double-blind placebo controlled trial of etanercept in patients with giant cell arteritis and corticosteroid side effects.","volume":"67","author":"Martinez-Taboada","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"R23-6-20210128","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1136\/ard.2005.036533","article-title":"Anti-CD20 monoclonal antibody (rituximab) as an adjunct in the treatment of giant cell arteritis.","volume":"64","author":"Bhatia","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"R24-6-20210128","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1093\/rheumatology\/29.6.456","article-title":"Interleukin-6 in serum of patients with polymyalgia rheumatica and giant cell arteritis.","volume":"29","author":"Dasgupta","year":"1990","journal-title":"Br J Rheumatol"},{"key":"R25-6-20210128","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0198-8859(94)90096-5","article-title":"Production of interleukin 6 by granulomas of giant cell arteritis.","volume":"39","author":"Emilie","year":"1994","journal-title":"Hum Immunol"},{"key":"R26-6-20210128","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1136\/ard.2008.090068","article-title":"Laboratory and febrile features after joint surgery in patients with rheumatoid arthritis treated with tocilizumab.","volume":"68","author":"Hirao","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"R27-6-20210128","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1161\/01.CIR.0000066907.83923.32","article-title":"Elevated production of interleukin-6 is associated with a lower incidence of disease-related ischemic events in patients with giant-cell arteritis: angiogenic activity of interleukin-6 as a potential protective mechanism.","volume":"107","author":"Hernandez-Rodriguez","year":"2003","journal-title":"Circulation"},{"key":"R28-6-20210128","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0140-6736(08)60453-5","article-title":"Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial.","volume":"371","author":"Smolen","year":"2008","journal-title":"Lancet"},{"key":"R29-6-20210128","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/BOR.0b013e3283456797","article-title":"The value of blocking IL-6 outside of rheumatoid arthritis: current perspective.","volume":"23","author":"Murakami","year":"2011","journal-title":"Curr Opin Rheumatol"},{"key":"R30-6-20210128","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1136\/ard.2010.149351","article-title":"Antiinterleukin 6 receptor therapy as rescue treatment for giant cell arteritis.","volume":"70","author":"Beyer","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"R31-6-20210128","first-page":"w13156","article-title":"Rapid induction of remission in large vessel vasculitis by IL-6 blockade: a case series.","volume":"141","author":"Seitz","year":"2011","journal-title":"Swiss Med Wkly"},{"key":"R32-6-20210128","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.3899\/jrheum.110496","article-title":"Interleukin 6 blockade as steroid-sparing treatment for 2 patients with giant cell arteritis.","volume":"38","author":"Sciascia","year":"2011","journal-title":"J Rheumatol"},{"key":"R33-6-20210128","first-page":"32","article-title":"Successful use if IL-6 blockade with tocilizumab in large vessel giant cell arteritis of polymyalgic onset.","volume":"50","author":"Christidis","year":"2011","journal-title":"Rheumatology"},{"key":"R34-6-20210128","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1002\/art.23373","article-title":"Successful treatment of a patient with Takayasu arteritis using a humanized antiinterleukin-6 receptor antibody.","volume":"58","author":"Nishimoto","year":"2008","journal-title":"Arthritis Rheum"},{"key":"R35-6-20210128","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/nrrheum.2010.82","article-title":"Takayasu arteritis: advances in diagnosis and management.","volume":"6","author":"Mason","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"R36-6-20210128","first-page":"777","article-title":"Takayasu arteritis: what is the long-term prognosis Rheum Dis Clin North A","volume":"33","author":"Maksimowicz-McKinnon","year":"2007","journal-title":"m"},{"key":"R37-6-20210128","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1002\/art.20300","article-title":"Antitumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis.","volume":"50","author":"Hoffman","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R38-6-20210128","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1136\/ard.2008.093260","article-title":"Antitumour necrosis factor therapy in patients with refractory Takayasu arteritis: long-term follow-up.","volume":"67","author":"Molloy","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"R40-6-20210128","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.autrev.2010.02.016","article-title":"Relapsing polychondritis: an autoimmune disease with many faces.","volume":"9","author":"Lahmer","year":"2010","journal-title":"Autoimmun Rev"},{"key":"R41-6-20210128","doi-asserted-by":"crossref","first-page":"74","DOI":"10.7326\/0003-4819-104-1-74","article-title":"Relapsing polychondritis: survival and predictive role of early disease manifestations.","volume":"104","author":"Michet","year":"1986","journal-title":"Ann Intern Med"},{"key":"R42-6-20210128","first-page":"96","article-title":"Relapsing polychondritis: clinical and immunogenetic analysis of 62 patients.","volume":"24","author":"Zeuner","year":"1997","journal-title":"J Rheumatol"},{"key":"R43-6-20210128","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1136\/jcp.54.11.890","article-title":"Active aortitis in relapsing polychondritis.","volume":"54","author":"Selim","year":"2001","journal-title":"J Clin Pathol"},{"key":"R44-6-20210128","doi-asserted-by":"crossref","first-page":"772","DOI":"10.4065\/81.6.772","article-title":"Surgical treatment of the cardiac manifestations of relapsing polychondritis: overview of 33 patients identified through literature review and the Mayo Clinic records.","volume":"81","author":"Dib","year":"2006","journal-title":"Mayo Clin Proc"},{"key":"R45-6-20210128","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0002-9343(85)90547-9","article-title":"Mouth and genital ulcers with inflamed cartilage: MAGIC syndrome: five patients with features of relapsing polychondritis and Behcets disease.","volume":"79","author":"Firestein","year":"1985","journal-title":"Am J Med"},{"key":"R46-6-20210128","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s10016-006-9046-7","article-title":"Transverse aortic arch replacement associated with MAGIC syndrome: case report and literature review.","volume":"20","author":"Caceres","year":"2006","journal-title":"Ann Vasc Surg"},{"key":"R47-6-20210128","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1093\/rheumatology\/kep224","article-title":"Sustained response to infliximab in a patient with relapsing polychondritis with aortic involvement.","volume":"48","author":"Marie","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"R48-6-20210128","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1093\/rheumatology\/kem229","article-title":"Prolonged response to antitumour necrosis factor treatment with adalimumab (Humira) in relapsing polychondritis complicated by aortitis.","volume":"46","author":"Seymour","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"R49-6-20210128","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1093\/rheumatology\/kep172","article-title":"Aortic aneurysm in MAGIC syndrome successfully managed with combined anti-TNF-alpha and stent grafting.","volume":"48","author":"Mekinian","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"R50-6-20210128","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s10067-007-0688-9","article-title":"Magic syndrome and true aortic aneurysm.","volume":"27","author":"Hidalgo-Tenorio","year":"2008","journal-title":"Clin Rheumatol"},{"key":"R51-6-20210128","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s00296-009-1308-6","article-title":"Treatment of relapsing polychondritis in the era of biological agents.","volume":"30","author":"McCarthy","year":"2010","journal-title":"Rheumatol Int"},{"key":"R52-6-20210128","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/BOR.0b013e3283410088","article-title":"Major vessel involvement in Behcets disease: an update.","volume":"23","author":"Calamia","year":"2011","journal-title":"Curr Opin Rheumatol"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0b013e32834dc392","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T23:02:34Z","timestamp":1620946954000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002281-201201000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0b013e32834dc392","relation":{},"ISSN":["1040-8711"],"issn-type":[{"value":"1040-8711","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}